Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.5K Buy
+52,700
New +$54.8K ﹤0.01% 13281
2025
Q2
– Sell
-800
Closed -$864 – 15085
2025
Q1
$864 Buy
+800
New +$782 ﹤0.01% 14206
2021
Q2
– Sell
-19,300
Closed -$53K – 14437
2021
Q1
$53K Buy
+19,300
New +$64K ﹤0.01% 12878

Other funds holding TLSA

Citadel Advisors's TLSA Position: Q3 2026 in Review

Citadel Advisors increased its Tiziana Life Sciences (TLSA) stake by 668% in Q3 2026, buying an estimated $557K and bringing the position to 615,965 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #9406.

Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold TLSA as of Q3 2026.

  • Citadel Advisors held 615,965 shares of Tiziana Life Sciences worth $684K as of Q3 2026.
  • Citadel Advisors bought 535,743 Tiziana Life Sciences shares in Q3 2026, an estimated $557K.
  • Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #9406 holding.
  • Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 11 quarters since.
  • 36 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.